世界のアルツハイマー病市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Alzheimer's Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0277 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、アルツハイマー病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ドネペジル、メマンチン、リバスチグミン）、用途別市場規模（初期～中程度段階、中程度～重度段階）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・アルツハイマー病の市場動向 ・企業の競争状況、市場シェア ・アルツハイマー病の種類別市場規模（ドネペジル、メマンチン、リバスチグミン） ・アルツハイマー病の用途別市場規模（初期～中程度段階、中程度～重度段階） ・アルツハイマー病の北米市場規模2016-2027（アメリカ、カナダ） ・アルツハイマー病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルツハイマー病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルツハイマー病の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルツハイマー病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck） ・結論

Market Analysis and Insights: Global Alzheimer’s Disease Market
The global Alzheimer’s Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimer’s Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimer’s Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimer’s Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimer’s Disease market.

Global Alzheimer’s Disease Scope and Market Size
Alzheimer’s Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Donepezil
Memantine
Rivastigmine

Segment by Application
Early to Moderate Stages
Moderate to Severe Stages

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alzheimer’s Disease Market Perspective (2016-2027)
2.2 Alzheimer’s Disease Growth Trends by Regions
2.2.1 Alzheimer’s Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alzheimer’s Disease Historic Market Share by Regions (2016-2021)
2.2.3 Alzheimer’s Disease Forecasted Market Size by Regions (2022-2027)
2.3 Alzheimer’s Disease Industry Dynamic
2.3.1 Alzheimer’s Disease Market Trends
2.3.2 Alzheimer’s Disease Market Drivers
2.3.3 Alzheimer’s Disease Market Challenges
2.3.4 Alzheimer’s Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Players by Revenue (2016-2021)
3.1.2 Global Alzheimer’s Disease Revenue Market Share by Players (2016-2021)
3.2 Global Alzheimer’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Disease Revenue
3.4 Global Alzheimer’s Disease Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Revenue in 2020
3.5 Alzheimer’s Disease Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Disease Product Solution and Service
3.7 Date of Enter into Alzheimer’s Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimer’s Disease Breakdown Data by Type
4.1 Global Alzheimer’s Disease Historic Market Size by Type (2016-2021)
4.2 Global Alzheimer’s Disease Forecasted Market Size by Type (2022-2027)

5 Alzheimer’s Disease Breakdown Data by Application
5.1 Global Alzheimer’s Disease Historic Market Size by Application (2016-2021)
5.2 Global Alzheimer’s Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alzheimer’s Disease Market Size (2016-2027)
6.2 North America Alzheimer’s Disease Market Size by Type
6.2.1 North America Alzheimer’s Disease Market Size by Type (2016-2021)
6.2.2 North America Alzheimer’s Disease Market Size by Type (2022-2027)
6.2.3 North America Alzheimer’s Disease Market Size by Type (2016-2027)
6.3 North America Alzheimer’s Disease Market Size by Application
6.3.1 North America Alzheimer’s Disease Market Size by Application (2016-2021)
6.3.2 North America Alzheimer’s Disease Market Size by Application (2022-2027)
6.3.3 North America Alzheimer’s Disease Market Size by Application (2016-2027)
6.4 North America Alzheimer’s Disease Market Size by Country
6.4.1 North America Alzheimer’s Disease Market Size by Country (2016-2021)
6.4.2 North America Alzheimer’s Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Alzheimer’s Disease Market Size (2016-2027)
7.2 Europe Alzheimer’s Disease Market Size by Type
7.2.1 Europe Alzheimer’s Disease Market Size by Type (2016-2021)
7.2.2 Europe Alzheimer’s Disease Market Size by Type (2022-2027)
7.2.3 Europe Alzheimer’s Disease Market Size by Type (2016-2027)
7.3 Europe Alzheimer’s Disease Market Size by Application
7.3.1 Europe Alzheimer’s Disease Market Size by Application (2016-2021)
7.3.2 Europe Alzheimer’s Disease Market Size by Application (2022-2027)
7.3.3 Europe Alzheimer’s Disease Market Size by Application (2016-2027)
7.4 Europe Alzheimer’s Disease Market Size by Country
7.4.1 Europe Alzheimer’s Disease Market Size by Country (2016-2021)
7.4.2 Europe Alzheimer’s Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Market Size (2016-2027)
8.2 Asia-Pacific Alzheimer’s Disease Market Size by Type
8.2.1 Asia-Pacific Alzheimer’s Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alzheimer’s Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alzheimer’s Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Alzheimer’s Disease Market Size by Application
8.3.1 Asia-Pacific Alzheimer’s Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alzheimer’s Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alzheimer’s Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Alzheimer’s Disease Market Size by Region
8.4.1 Asia-Pacific Alzheimer’s Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alzheimer’s Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alzheimer’s Disease Market Size (2016-2027)
9.2 Latin America Alzheimer’s Disease Market Size by Type
9.2.1 Latin America Alzheimer’s Disease Market Size by Type (2016-2021)
9.2.2 Latin America Alzheimer’s Disease Market Size by Type (2022-2027)
9.2.3 Latin America Alzheimer’s Disease Market Size by Type (2016-2027)
9.3 Latin America Alzheimer’s Disease Market Size by Application
9.3.1 Latin America Alzheimer’s Disease Market Size by Application (2016-2021)
9.3.2 Latin America Alzheimer’s Disease Market Size by Application (2022-2027)
9.3.3 Latin America Alzheimer’s Disease Market Size by Application (2016-2027)
9.4 Latin America Alzheimer’s Disease Market Size by Country
9.4.1 Latin America Alzheimer’s Disease Market Size by Country (2016-2021)
9.4.2 Latin America Alzheimer’s Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Market Size (2016-2027)
10.2 Middle East & Africa Alzheimer’s Disease Market Size by Type
10.2.1 Middle East & Africa Alzheimer’s Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alzheimer’s Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alzheimer’s Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Alzheimer’s Disease Market Size by Application
10.3.1 Middle East & Africa Alzheimer’s Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alzheimer’s Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alzheimer’s Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Alzheimer’s Disease Market Size by Country
10.4.1 Middle East & Africa Alzheimer’s Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alzheimer’s Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Alzheimer’s Disease Introduction
11.1.4 Allergan Revenue in Alzheimer’s Disease Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer’s Disease Introduction
11.2.4 Eisai Revenue in Alzheimer’s Disease Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer’s Disease Introduction
11.3.4 Novartis Revenue in Alzheimer’s Disease Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Details
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Alzheimer’s Disease Introduction
11.4.4 Daiichi Sankyo Revenue in Alzheimer’s Disease Business (2016-2021)
11.4.5 Daiichi Sankyo Recent Development
11.5 Merz Pharma
11.5.1 Merz Pharma Company Details
11.5.2 Merz Pharma Business Overview
11.5.3 Merz Pharma Alzheimer’s Disease Introduction
11.5.4 Merz Pharma Revenue in Alzheimer’s Disease Business (2016-2021)
11.5.5 Merz Pharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Alzheimer’s Disease Introduction
11.6.4 Pfizer Revenue in Alzheimer’s Disease Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Alzheimer’s Disease Introduction
11.7.4 Johnson & Johnson Revenue in Alzheimer’s Disease Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Details
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Alzheimer’s Disease Introduction
11.8.4 Lundbeck Revenue in Alzheimer’s Disease Business (2016-2021)
11.8.5 Lundbeck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alzheimer's Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Donepezil
Table 3. Key Players of Memantine
Table 4. Key Players of Rivastigmine
Table 5. Global Alzheimer's Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Alzheimer's Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alzheimer's Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Alzheimer's Disease Market Share by Regions (2016-2021)
Table 9. Global Alzheimer's Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Alzheimer's Disease Market Share by Regions (2022-2027)
Table 11. Alzheimer's Disease Market Trends
Table 12. Alzheimer's Disease Market Drivers
Table 13. Alzheimer's Disease Market Challenges
Table 14. Alzheimer's Disease Market Restraints
Table 15. Global Alzheimer's Disease Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Alzheimer's Disease Market Share by Players (2016-2021)
Table 17. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease as of 2020)
Table 18. Ranking of Global Top Alzheimer's Disease Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Alzheimer's Disease Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alzheimer's Disease Product Solution and Service
Table 22. Date of Enter into Alzheimer's Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer's Disease Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Alzheimer's Disease Revenue Market Share by Type (2016-2021)
Table 26. Global Alzheimer's Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Alzheimer's Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Alzheimer's Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Alzheimer's Disease Revenue Market Share by Application (2016-2021)
Table 30. Global Alzheimer's Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Alzheimer's Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Alzheimer's Disease Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Alzheimer's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Alzheimer's Disease Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Alzheimer's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Alzheimer's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Alzheimer's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Alzheimer's Disease Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Alzheimer's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Alzheimer's Disease Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Alzheimer's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Alzheimer's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Alzheimer's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Alzheimer's Disease Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Alzheimer's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alzheimer's Disease Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alzheimer's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alzheimer's Disease Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Alzheimer's Disease Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Alzheimer's Disease Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Alzheimer's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Alzheimer's Disease Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Alzheimer's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Alzheimer's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Alzheimer's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Alzheimer's Disease Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Alzheimer's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alzheimer's Disease Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alzheimer's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alzheimer's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Alzheimer's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Alzheimer's Disease Product
Table 65. Allergan Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Eisai Company Details
Table 68. Eisai Business Overview
Table 69. Eisai Alzheimer's Disease Product
Table 70. Eisai Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 71. Eisai Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Alzheimer's Disease Product
Table 75. Novartis Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Daiichi Sankyo Company Details
Table 78. Daiichi Sankyo Business Overview
Table 79. Daiichi Sankyo Alzheimer's Disease Product
Table 80. Daiichi Sankyo Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 81. Daiichi Sankyo Recent Development
Table 82. Merz Pharma Company Details
Table 83. Merz Pharma Business Overview
Table 84. Merz Pharma Alzheimer's Disease Product
Table 85. Merz Pharma Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 86. Merz Pharma Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Alzheimer's Disease Product
Table 90. Pfizer Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Alzheimer's Disease Product
Table 95. Johnson & Johnson Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Lundbeck Company Details
Table 98. Lundbeck Business Overview
Table 99. Lundbeck Revenue in Alzheimer's Disease Business (2016-2021) & (US$ Million)
Table 100. Lundbeck Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Market Share by Type: 2020 VS 2027
Figure 2. Donepezil Features
Figure 3. Memantine Features
Figure 4. Rivastigmine Features
Figure 5. Global Alzheimer's Disease Market Share by Application: 2020 VS 2027
Figure 6. Early to Moderate Stages Case Studies
Figure 7. Moderate to Severe Stages Case Studies
Figure 8. Alzheimer's Disease Report Years Considered
Figure 9. Global Alzheimer's Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Alzheimer's Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Alzheimer's Disease Market Share by Regions: 2020 VS 2027
Figure 12. Global Alzheimer's Disease Market Share by Regions (2022-2027)
Figure 13. Global Alzheimer's Disease Market Share by Players in 2020
Figure 14. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Alzheimer's Disease Revenue in 2020
Figure 16. Global Alzheimer's Disease Revenue Market Share by Type (2016-2021)
Figure 17. Global Alzheimer's Disease Revenue Market Share by Type (2022-2027)
Figure 18. North America Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Alzheimer's Disease Market Share by Type (2016-2027)
Figure 20. North America Alzheimer's Disease Market Share by Application (2016-2027)
Figure 21. North America Alzheimer's Disease Market Share by Country (2016-2027)
Figure 22. United States Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Alzheimer's Disease Market Share by Type (2016-2027)
Figure 26. Europe Alzheimer's Disease Market Share by Application (2016-2027)
Figure 27. Europe Alzheimer's Disease Market Share by Country (2016-2027)
Figure 28. Germany Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Alzheimer's Disease Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Alzheimer's Disease Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Alzheimer's Disease Market Share by Region (2016-2027)
Figure 38. China Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Alzheimer's Disease Market Share by Type (2016-2027)
Figure 46. Latin America Alzheimer's Disease Market Share by Application (2016-2027)
Figure 47. Latin America Alzheimer's Disease Market Share by Country (2016-2027)
Figure 48. Mexico Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Alzheimer's Disease Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Alzheimer's Disease Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Alzheimer's Disease Market Share by Country (2016-2027)
Figure 54. Turkey Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Alzheimer's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Allergan Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 58. Eisai Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 61. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 64. Lundbeck Revenue Growth Rate in Alzheimer's Disease Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---